Drugs / VEE C-84
VEE C-84
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00582088 | Mar 2008 → Jun 2021 | Venezuelan equine encephalitis | U.S. Army Medical Research and Development Command | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VEE C-84 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00582088 ↗ |
| Known as | TSI-GSD 205 | “VEE C-84 - Venezuelan Equine Encephalomyelitis Vaccine, Inactivated, Dried, C-84, TSI-GSD 205” NCT00582088 ↗ |
| Known as | Venezuelan Equine Encephalomyelitis Vaccine, Inactivated, Dried, C-84 | “VEE C-84 - Venezuelan Equine Encephalomyelitis Vaccine, Inactivated, Dried, C-84, TSI-GSD 205” NCT00582088 ↗ |
| Modality | Vaccine | “Venezuelan Equine Encephalomyelitis Vaccine” NCT00582088 ↗ |
| Route | Subcutaneous | “0.5 mL subcutaneous injection” NCT00582088 ↗ |